Public Policy Resources

The American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Senate Finance Committee on the Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients.

The American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program Proposed Rule.

This factsheet explains what health care tax credits (also known as "enhanced tax credits") are and why Congress needs to extend them before they expire at the end of the year.

Drug therapies are the bedrock of cancer care. Making these therapies affordable, while continuing to encourage innovation of new treatments, is crucial to accomplishing the mission of the American Cancer Society Cancer Action Network (ACS CAN) to end cancer as we know it, for everyone. ACS CAN has long fought for public policies that support both the affordability and availability of medically necessary prescription drugs. 
 

Access to affordable health insurance is crucial for individuals to receive necessary care, especially for those with chronic conditions like cancer.

This factsheet provides background information on how the enhanced ACA tax credits benefit those in rural communities. 

This factsheet provides basic information about the enhanced ACA tax credits.

Prescription drug costs are a significant burden on cancer patients and survivors, sometimes even leading patients to miss or delay taking prescribed medications. The latest Survivor Views survey explores the role copay assistance programs can play in reducing this burden, and also addresses patient navigation and digital therapeutics.

A majority of cancer patients and survivors struggle to afford cancer care and over 80% have had to make financial sacrifices to cover their health care expenses. This survey also reveals ways that affordability concerns can negatively impact care and treatment, and explores issues related to prescription drug coverage and pain management options.